Rare diseases
Investigational molecules
Locations
Study on Belantamab Mafodotin for Patients with Relapsed or Refractory Multiple Myeloma
PolandLong-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension
PolandStudy of Datopotamab Deruxtecan and Durvalumab for Adults with Untreated Triple-Negative or Hormone Receptor-Low/HER2-Negative Breast Cancer
PolandStudy on the Safety of Tafasitamab and Lenalidomide for Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma
PolandStudy Comparing Camizestrant and Palbociclib with Anastrozole and Palbociclib for Patients with ER-Positive, HER2-Negative Advanced Breast Cancer Without Prior Treatment
PolandStudy of Nivolumab or Placebo for Patients with Removed Esophageal or Gastroesophageal Junction Cancer
PolandStudy on the Effects of AMX0035 (Phenylbutyrate and Ursodoxicoltaurine) in Patients with Progressive Supranuclear Palsy
PolandStudy on Atezolizumab and Trastuzumab Emtansine for Patients with HER2-Positive Breast Cancer at High Risk of Recurrence After Preoperative Therapy
PolandStudy Comparing Acalabrutinib and Venetoclax with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PolandStudy on Olaparib for Patients with High-Risk HER2-Negative Breast Cancer and BRCA1/2 Mutations After Chemotherapy
PolandStudy of Olaparib for Patients with Advanced BRCA-Mutated Ovarian Cancer After Initial Platinum-Based Chemotherapy
PolandStudy on the Safety and Immune Response of V116 Vaccine in Children and Adolescents at Higher Risk for Pneumococcal Disease
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
